Memorandum
To: Market Participants
From: NZX Product Operations
Date: Monday, 24 February 2025
Subject: Ryman Healthcare Limited (“RYM”) – Trading Halt of Securities
Message:
NZ RegCo has approved a trading halt application from Ryman Healthcare Limited (“RYM”). Trading in RYM equity and quoted debt securities was halted prior to market pre-open today.
Attached is the trading halt application, for further information.
Please contact NZX Product Operations on +64 4 496 2853 or [email protected] with any queries.
ENDS
"We may have seen the worst of the tariff announcements ..."
In early trade in Asia on Friday, Japan's Nikkei tumbled more than 5%.
The new shares will be priced at $36.65.
To join your company account for BusinessDesk and enjoy full access, enter your email and we’ll send you details